EZH2 is a H3K27 methyltransferase that has been recognized as a gene transcriptional regulator and a cancer driver, mainly through its ability to epigenetically and globally modify tumor-related genes (Kim and Roberts, 2016; Wang et al., 2017). The gene discussed is EZH2; the disease is neoplasm.